Almac opens £20m cold chain facility

By Melissa Fassbender contact

- Last updated on GMT

(Image: Almac Group)
(Image: Almac Group)
Almac Group has opened a 95,000 square foot, custom-built cold store facility, which is one of the largest of its kind in Europe, says CDMO.

The global contract pharmaceutical development and manufacturing organization (CDMO) has completed a £20m ($27.59m) investment in its cold chain management capabilities.

The expansion ups the company’s cold storage capacity by 300% and its frozen storage capabilities by more than 50%, commented Almac Group CEO Alan Armstrong.

Dr Robert Dunlop, MD, president, Almac Clinical Services, told us the investment forms part of the company's overall expansion strategy and complements its existing facilities at its headquarters in Northern Ireland.

"Both clinical and commercial client requirements were a priority throughout the design and construction of this new facility, giving consideration to the uptake in orphan drug products, changes to regulatory compliance and a more stringent focus on data across the supply chain," ​explained Dunlop.

"Due to this additional capacity, clients have the option to scale up with Almac as their biologic/biosimilar product portfolio increases,” ​he added. 

The new facility features more than 3,000 pallet spaces including -15°C to -25°C storage capacity, additional 2°C - 8°C secondary production rooms, in addition to 3PL processing areas and a clinical labeling suite. 

Almac expects to hire an additional 100 new employees as part of the expansion.

To meet client needs in the EU, the company also recently announced a £30m ($41.36) investment at its new European campus based in Dundalk, Ireland. Scheduled to be operationally ready by January 2019, the expansion includes a new QC laboratory, packaging facility for commercial drug products and a 79,000 square foot distribution center for clinical trial supply.

Related news

Show more

Related products

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Baxter BioPharma Solutions | 01-Mar-2020 | Technical / White Paper

Recent market reports suggest increasing product niches, which may lead to decreasing numbers of units per product, making dedicated facilities less practical....

What do big pharma companies spend on R&D?

What do big pharma companies spend on R&D?

Zymewire | 15-Aug-2019 | Technical / White Paper

The free Big Pharma R&D Spend report examines the financial performance and research & development investments of the top 25 pharmaceutical companies...

Related suppliers

Follow us


View more